WPA

Bupa has been the latest to warn about the nearing ‘affordability crunch' in the private medical insurance market as premiums continue to rise. What genuine, clean slate innovation would you like to see in PMI - and how possible will real innovation be?...

The group PMI market has been a little flat of late. So why not try to dazzle it? That's the consensus view of some providers, as Nicola Culley reports.

Intermediaries queried corporate deductible PMI products today at an educational seminar held by WPA in London.

The growing take-up of corporate deductible PMI products wis likely to invite greater HMRC scrutiny, Axa PPP has warned.

Westfield Health has recently released a new product, Hospital Treatment Insurance, aimed at the middle ground between cash plans and PMI. Considering the lengthening of hospital waiting lists, could this be the birth of a third tier to the health insurance...

Simplyhealth has plans to expand its offering with a corporate deductible-style group PMI.

Private medical Insurers (PMI) have endorsed the Office of Fair Trading referring the UK healthcare market to the Competition Commission and said they will take an active part in investigations.

Private Medical Insurance (PMI) provider WPA has released evidence the tax treatment of its Corporate Deductible schemes is sanctioned by the taxman.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

WPA has introduced moratorium underwriting on its individual private medical insurance (PMI) plans for clients who fit certain criteria.